Developing sustainable workflows for community pharmacy-based SARS-CoV-2 testing

Area of Science:

• Public Health
• Pharmaceutical Sciences
• Epidemiology

Background:

• The coronavirus disease (COVID-19) pandemic necessitated rapid expansion of testing capabilities.
• Community pharmacies played a crucial role in public health responses during the crisis.

Purpose of the Study:

• To rapidly design, implement, and disseminate a pharmacy-based point-of-care testing program.
• To enhance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing accessibility in community settings.

Main Methods:

• A drive-thru model was adopted to ensure safety for pharmacy staff and the public.
• Community pharmacies in Idaho were recruited, with a focus on underserved and remote areas.
• Iterative development of workflows, e-Care plans, and a web portal for reporting positive results.

Main Results:

• 13 pharmacies conducted 2425 tests between September and December 2020.
• Approximately 29.4% of point-of-care tests were positive, with 70.6% requiring PCR confirmation.
• Pharmacies provided an average of 77.5 hours of testing weekly, contributing significantly to statewide testing efforts.

Conclusions:

• Community-based pharmacies are valuable partners in public health initiatives.
• Pharmacy-led testing programs can effectively increase access to diagnostic services.
• The rapid antigen testing program demonstrated adaptability and scalability in response to a public health emergency.